The health firm says revenues from continuing operations increased 4.9% to £74.2m (2023: £70.7m), while pre-tax profits went up to £5.8m (2023: £3.3m).
As previously reported, the business bought Australia-based Randlab in January 2025 for £59.7m, transforming its position in the Equine sector and opening new routes to Asia Pacific markets for its products.
RECOMMENDED READING:
Jenny Winter, chief executive officer, said: “This has been a solid year of delivery for Animalcare, characterised by a positive organic trading performance and culminating in the exciting acquisition of Randlab post year end, providing a transformational boost to the execution of our long-term growth strategy.
“Revenues increased across all three of our product categories as investment in our people and the effectiveness of our operations continued to yield benefits.”
“Strong cash generation, underpinned by the disposal of non-core assets and the proceeds of the successful equity raise, maintained our balance sheet firepower, enabling us to continue the pursuit of organic and inorganic growth opportunities.”
